Foralumab
Term · Oncology and biomedicine · MLC-T-ONC-013749
A monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon, with immunomodulatory activity. Foralumab binds to CD3 epsilon on T cells, preventing T-cell activation and may also suppress immune responses. CD3 epsilon is a polypeptide that is part of the CD3-T cell receptor (TCR) complex.
| Identifier | MLC-T-ONC-013749 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013749",
"term": "Foralumab",
"field": "Oncology and biomedicine",
"definition": "A monoclonal antibody directed against cluster of differentiation 3 (CD3) epsilon, with immunomodulatory activity. Foralumab binds to CD3 epsilon on T cells, preventing T-cell activation and may also suppress immune responses. CD3 epsilon is a polypeptide that is part of the CD3-T cell receptor (TCR) complex.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/foralumab/"
}
Record 7,558 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.